Answers are grounded in this paper and cite their sources.
Retrospective cohort study shows high systemic immune-inflammatory index increases MACE risk in patients undergoing TAVR, suggesting need for further validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Han et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: